Provider

Respiray’s wearable device allegedly kills over 99% of viruses and bacteria with UV light and filter.

In a recent study funded and coauthored by the company, the EaseVRx program outperformed a non-interactive headset app across several self-reported pain and pain-interference measures.

The process aims to ensure tools meet NHS standards.

Digitally treating osteoarthritis through clinical, evidence-based programs can be more effective at reducing pain and improving physical function than routine self-managed care, according to research from JAMA Network Open.

Google has been working with Ascension on a pilot of the program, which it is now expanding. 

The solution provides personalised patient support to those who need it most.

The smartphone-enabled LooK SPOT test scans for nucleocapsid protein from SARS-CoV-2 in nasal swabs, with results reportedly available in five to eight minutes.

The University Health Network study is being conducted in collaboration with the tech giant, and will enroll roughly 200 patients for three months of active monitoring with a two-year follow-up.

An article in NEJM reports that pulse oximeters missed occult hypoxemia in more Black patients than white.

Also: Cityblock Health adds former Livongo president to its board of directors; Virta Health's new CFO targets rapid growth.